180464-87-3

Basic information

• Product Name: Bicyclo[1.1.1]pentane-1-carboxylic acid, 3-(hydroxymethyl)-, methyl ester (9CI)
• Synonyms: Bicyclo[1.1.1]pentane-1-carboxylic acid, 3-(hydroxymethyl)-, methyl ester (9CI);Methyl 3-(hydroxyMethyl)bicyclo[1.1.1]pentane-1-carboxylate;methyl 1-(hydroxymethyl)bicyclo[1.1.1]pentane-3-carboxylate
• CAS NO: 180464-87-3
• Molecular Formula: C₈H₁₂O₃
• Molecular Weight: 156.17908
• Product Categories: CARBOXYLICESTER
• Mol File: 180464-87-3.mol
• Article Data: 18

Chemical Properties

• Boiling Point: 212.3±13.0 °C(Predicted)
• Appearance: /
• Density: 1.352±0.06 g/cm3(Predicted)
• Storage Temp.: Sealed in dry,Room Temperature
• PKA: 15.16±0.10(Predicted)
• CAS DataBase Reference: Bicyclo[1.1.1]pentane-1-carboxylic acid, 3-(hydroxymethyl)-, methyl ester (9CI)(CAS DataBase Reference)
• NIST Chemistry Reference: Bicyclo[1.1.1]pentane-1-carboxylic acid, 3-(hydroxymethyl)-, methyl ester (9CI)(180464-87-3)
• EPA Substance Registry System: Bicyclo[1.1.1]pentane-1-carboxylic acid, 3-(hydroxymethyl)-, methyl ester (9CI)(180464-87-3)

Safety Data

• Hazardous Substances Data: 180464-87-3(Hazardous Substances Data)

Usage

General Description

Bicyclo[1.1.1]pentane-1-carboxylic acid, 3-(hydroxymethyl)-, methyl ester (9CI) is a chemical compound with the molecular formula C9H14O3. It is a methyl ester derivative of the bicyclic compound bicyclo[1.1.1]pentane-1-carboxylic acid, which contains a hydroxymethyl group at the 3-position. Bicyclo[1.1.1]pentane-1-carboxylic acid, 3-(hydroxymethyl)-, methyl ester (9CI) has potential applications in pharmaceuticals, as well as in the field of organic synthesis. It is important to handle this compound with care, as it may present hazards such as flammability and skin irritation. Due to its specific chemical structure, it may have unique reactivity and properties that make it valuable for certain chemical processes and applications.

Upstream product

• 109-02-4 4-methyl-morpholine 
• 115913-30-9 1,1′-(bicyclo[1.1.1]pentane-1,3-diyl)bis(ethan-1-one) 
• 115913-32-1 dimethyl bicyclo<1.1.1>pentane-1,3-dicarboxylate 
• 115913-31-0 1,3-bis(chlorocarbonyl)bicyclo<1.1.1>pentane 
• 83249-10-9 3‐(methoxycarbonyl)bicyclo[1.1.1]pentane‐1‐carboxylic acid 
• 56842-95-6 bicyclo<1.1.1>pentane-1,3-dicarboxylic acid 
• 311-75-1 bicyclo[1.1.1]pentane 

Downstream Products

• 1113001-95-8 C₂₀H₂₉N₂O₄P 
• 1113001-93-6 C₂₀H₂₉N₂O₄P 
• 180464-92-0 3-formylbicyclo[1.1.1]pentane-1-carboxylic acid methyl ester 
• 180464-96-4 3-[(S)-Cyano-((R)-2-hydroxy-1-phenyl-ethylamino)-methyl]-bicyclo[1.1.1]pentane-1-carboxylic acid methyl ester 
• 180465-00-3 3-[(R)-Cyano-((R)-2-hydroxy-1-phenyl-ethylamino)-methyl]-bicyclo[1.1.1]pentane-1-carboxylic acid methyl ester 

Relevant articles and documents

SSAO INHIBITORS AND USE THEREOF

Provided are a compound of formula (I') or (I), a pharmaceutically acceptable salt, hydrate, solvate, prodrug, stereoisomer, or tautomer thereof, which modulates the activity of SSAO, a pharmaceutical composition comprising a compound of formula (I') or (I), and a method of treating or preventing a disease in which SSAO plays a role.

LACTAM COMPOUND AS FXR RECEPTOR AGONIST

Disclosed is a compound as shown in formula (I), an optical isomer thereof or a pharmaceutically acceptable salt thereof, and the present invention relates to the use of same in the preparation of a drug for treating FXR-related diseases.

CYCLOBUTYL CARBOXYLIC ACIDS AS LPA ANTAGONISTS

The present invention provides compounds of Formula (I): (I), or a stereoisomer, tautomer, or pharmaceutically acceptable salt or solvate thereof, wherein all the variables are as defined herein. These compounds are selective LPA receptor inhibitors.